Investing.com – Alpha Tau Medical reported on Tuesday third quarter that beat analysts’ forecasts and revenue that was inline with expectations.
Alpha Tau Medical announced earnings per share of $-0.040 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.116 on revenue of $0.00.
Alpha Tau Medical shares are down 61% from the beginning of the year and are trading at $3.750 , down-from-52-week-high.
Alpha Tau Medical follows other major Healthcare sector earnings this month
Alpha Tau Medical’s report follows an earnings beat by Eli Lilly on Tuesday, November 1, 2022, who reported EPS of $1.98 on revenue of $6.94B, compared to forecasts EPS of $1.91 on revenue of $6.91B.
AbbVie had beat expectations on Friday, October 28, 2022 with third quarter EPS of $3.66 on revenue of $14.81B, compared to forecast for EPS of $3.58 on revenue of $14.93B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
Read More: Alpha Tau Medical earnings beat, Revenue Inline in Q3
